[September 15, 2017]

US Tumor Marker Testing Analyzers and Reagents Market 2021 - Research and Markets

The "US Tumor Marker Testing Analyzers and Reagents Market 2021: Supplier Shares and Sales Forecasts - Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers" report has been added to Research and Markets' offering.

US Tumor Marker Testing Analyzers and Reagents Market 2021 provides Supplier Shares and Sales Forecasts with Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

Highlights

• Comprehensive 620-page analysis of the US tumor marker testing market.
• Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
• Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, ancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
• Five-year test volume and sales forecasts over for 40 tumor marker performed in US hospitals, commercial laboratories and physician offices.
• Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.
• Current instrumentation technologies and feature comparison of leading analyzers.
• Sales and market shares of leading suppliers.
• Emerging diagnostic technologies and their potential market applications.
• Product development opportunities.
• Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Business opportunities and strategic recommendations for suppliers.

• Abbott
• AdnaGen/Alere
• Agilent (News - Alert) Technologies
• Applied Gene Technologies
• Arca Biopharma
• Beckman Coulter/Danaher
• Becton Dickinson
• Biomedical Diagnostics
• bioMerieux
• Bio-Rad
• CellSearch
• Cepheid
• Correlogic Systems/Vermillion

For more information about this report visit https://www.researchandmarkets.com/research/cnpfvr/us_tumor_marker

View source version on businesswire.com: http://www.businesswire.com/news/home/20170915005515/en/

[ Back To TMCnet.com's Homepage ]